{"title":"急性 Lisfranc 损伤的初次关节固定术与开放复位内固定术:系统回顾与荟萃分析","authors":"Kyle P. O’Connor, Logan B. Tackett, John T. Riehl","doi":"10.1007/s00402-024-05700-z","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>The presence of a Lisfranc injury alone is considered a surgical indication in most patients. Indications for primary arthrodesis (PA) versus open reduction internal fixation (ORIF), however, is a topic of debate among surgeons. Conflicting data exists as to which treatment modality leads to improved patient-reported outcome measures (PROMs), reoperations, and complications.</p><h3>Methods</h3><p>Databases queried included PubMed, OVID Medline, Embase, SCOPUS, Cochrane Central Register of Clinical Trials, and clinicaltrials.gov from their dates of inception to 3/21/2024. Studies were incorporated into this analysis if they had included patients with acute Lisfranc injuries and compared outcomes between PA and ORIF. PROMs, reoperations, and complications were captured. Results were reported as effect sizes (ES) and odds ratios (OR).</p><h3>Results</h3><p>There were eighteen studies included in this SRMA. Pooled data from 13/16 studies that reported AOFAS and VAS demonstrated better outcomes after PA compared to ORIF. AOFAS was 84.4 ± 28.5 after PA and 75.7 ± 29.0 after ORIF. VAS pain was 1.4 ± 2.7 after PA and 2.0 ± 3.3 after ORIF. There were 3 more studies that reported other PROMs and favored ORIF. Return to preinjury activity was 79.2% after PA and 65.7% after ORIF. The prevalence of midfoot post-traumatic arthritis was reported as 2.8% after PA and 17.3% after ORIF. Adjacent joint arthritis was not reported in the current literature. After PA, 77/438 (17.6%) patients underwent reoperations, and after ORIF, 514/802 (64.1%) patients underwent reoperations. After excluding planned hardware removals, relative rates of unplanned reoperations were 14.7% (n = 62/423) after PA and 38.3% (n = 181/472) after ORIF (<i>p</i> < 0.001). Non-operative complications occurred in 43/406 (10.6%) patients after PA and 95/753 (12.6%) patients after ORIF (<i>p</i> = 0.31). Meta-analyses demonstrated that AOFAS (ES: 0.41, CI 0.13, 0.68, <i>p</i> = 0.004) and VAS pain (ES: − 0.53, CI − 0.91, − 0.15, <i>p</i> = 0.006), and return to activity rates (OR: 2.71, CI 1.43, 6.39) favored PA over ORIF. Post-traumatic arthritis (OR: 0.29, CI 0.11, 0.77) and reoperations (OR: 0.16, CI 0.06, 0.44) were less prevalent after PA compared to ORIF.</p><h3>Conclusion</h3><p>This systematic review and meta-analysis suggested that PA provides better short- and medium-term outcomes in the setting of Lisfranc injuries when compared to ORIF with rigid fixation. Due to a lack of available clinical studies, the long-term effects of PA are largely unknown but may include increased adjacent joint arthritis, pain, and need for further surgery—especially in young and active patients. Future research demonstrating long-term outcomes would be helpful in clinical decision making.</p><h3>Level of evidence</h3><p>I.</p></div>","PeriodicalId":8326,"journal":{"name":"Archives of Orthopaedic and Trauma Surgery","volume":"145 1","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Primary arthrodesis versus open reduction internal fixation for acute Lisfranc injuries: a systematic review and meta-analysis\",\"authors\":\"Kyle P. O’Connor, Logan B. Tackett, John T. Riehl\",\"doi\":\"10.1007/s00402-024-05700-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>The presence of a Lisfranc injury alone is considered a surgical indication in most patients. Indications for primary arthrodesis (PA) versus open reduction internal fixation (ORIF), however, is a topic of debate among surgeons. Conflicting data exists as to which treatment modality leads to improved patient-reported outcome measures (PROMs), reoperations, and complications.</p><h3>Methods</h3><p>Databases queried included PubMed, OVID Medline, Embase, SCOPUS, Cochrane Central Register of Clinical Trials, and clinicaltrials.gov from their dates of inception to 3/21/2024. Studies were incorporated into this analysis if they had included patients with acute Lisfranc injuries and compared outcomes between PA and ORIF. PROMs, reoperations, and complications were captured. Results were reported as effect sizes (ES) and odds ratios (OR).</p><h3>Results</h3><p>There were eighteen studies included in this SRMA. Pooled data from 13/16 studies that reported AOFAS and VAS demonstrated better outcomes after PA compared to ORIF. AOFAS was 84.4 ± 28.5 after PA and 75.7 ± 29.0 after ORIF. VAS pain was 1.4 ± 2.7 after PA and 2.0 ± 3.3 after ORIF. There were 3 more studies that reported other PROMs and favored ORIF. Return to preinjury activity was 79.2% after PA and 65.7% after ORIF. The prevalence of midfoot post-traumatic arthritis was reported as 2.8% after PA and 17.3% after ORIF. Adjacent joint arthritis was not reported in the current literature. After PA, 77/438 (17.6%) patients underwent reoperations, and after ORIF, 514/802 (64.1%) patients underwent reoperations. After excluding planned hardware removals, relative rates of unplanned reoperations were 14.7% (n = 62/423) after PA and 38.3% (n = 181/472) after ORIF (<i>p</i> < 0.001). Non-operative complications occurred in 43/406 (10.6%) patients after PA and 95/753 (12.6%) patients after ORIF (<i>p</i> = 0.31). Meta-analyses demonstrated that AOFAS (ES: 0.41, CI 0.13, 0.68, <i>p</i> = 0.004) and VAS pain (ES: − 0.53, CI − 0.91, − 0.15, <i>p</i> = 0.006), and return to activity rates (OR: 2.71, CI 1.43, 6.39) favored PA over ORIF. Post-traumatic arthritis (OR: 0.29, CI 0.11, 0.77) and reoperations (OR: 0.16, CI 0.06, 0.44) were less prevalent after PA compared to ORIF.</p><h3>Conclusion</h3><p>This systematic review and meta-analysis suggested that PA provides better short- and medium-term outcomes in the setting of Lisfranc injuries when compared to ORIF with rigid fixation. Due to a lack of available clinical studies, the long-term effects of PA are largely unknown but may include increased adjacent joint arthritis, pain, and need for further surgery—especially in young and active patients. Future research demonstrating long-term outcomes would be helpful in clinical decision making.</p><h3>Level of evidence</h3><p>I.</p></div>\",\"PeriodicalId\":8326,\"journal\":{\"name\":\"Archives of Orthopaedic and Trauma Surgery\",\"volume\":\"145 1\",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-12-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Orthopaedic and Trauma Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00402-024-05700-z\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Orthopaedic and Trauma Surgery","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00402-024-05700-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
摘要
在大多数患者中,仅存在Lisfranc损伤被认为是手术指征。然而,原发性关节融合术(PA)与切开复位内固定(ORIF)的适应症是外科医生争论的话题。关于哪种治疗方式可以改善患者报告的结果测量(PROMs)、再手术和并发症,存在矛盾的数据。方法查询的数据库包括PubMed、OVID Medline、Embase、SCOPUS、Cochrane Central Register of Clinical Trials和clinicaltrials.gov,检索时间为数据库成立日期至2024年3月21日。如果研究纳入了急性Lisfranc损伤患者,并比较了PA和ORIF的结果,则纳入该分析。记录prom、再手术和并发症。结果以效应量(ES)和优势比(OR)报告。结果本研究共纳入18项研究。来自13/16个报告AOFAS和VAS的研究的汇总数据显示,与ORIF相比,PA后的结果更好。PA术后AOFAS为84.4±28.5,ORIF术后AOFAS为75.7±29.0。PA术后VAS疼痛1.4±2.7,ORIF术后VAS疼痛2.0±3.3。还有3个研究报告了其他prom和支持ORIF。PA和ORIF术后损伤前活动恢复率分别为79.2%和65.7%。PA术后中足创伤后关节炎患病率为2.8%,ORIF术后为17.3%。目前文献中未见邻关节关节炎的报道。PA术后77/438例(17.6%)患者再次手术,ORIF术后514/802例(64.1%)患者再次手术。排除计划内的硬体移除后,PA术后非计划再手术的相对发生率为14.7% (n = 62/423), ORIF术后为38.3% (n = 181/472) (p < 0.001)。PA术后43/406例(10.6%)、ORIF术后95/753例(12.6%)出现非手术并发症(p = 0.31)。荟萃分析表明,AOFAS (ES: 0.41, CI 0.13, 0.68, p = 0.004)和VAS疼痛(ES: - 0.53, CI - 0.91, - 0.15, p = 0.006)和恢复活动率(OR: 2.71, CI 1.43, 6.39)优于ORIF。与ORIF相比,PA术后创伤后关节炎(OR: 0.29, CI 0.11, 0.77)和再手术(OR: 0.16, CI 0.06, 0.44)发生率较低。本系统综述和荟萃分析表明,与ORIF +刚性固定相比,PA在Lisfranc损伤的治疗中提供了更好的短期和中期结果。由于缺乏可用的临床研究,PA的长期影响在很大程度上是未知的,但可能包括增加邻近关节关节炎,疼痛和需要进一步手术-特别是在年轻和活跃的患者中。未来的研究表明,长期的结果将有助于临床决策。证据水平。
Primary arthrodesis versus open reduction internal fixation for acute Lisfranc injuries: a systematic review and meta-analysis
Introduction
The presence of a Lisfranc injury alone is considered a surgical indication in most patients. Indications for primary arthrodesis (PA) versus open reduction internal fixation (ORIF), however, is a topic of debate among surgeons. Conflicting data exists as to which treatment modality leads to improved patient-reported outcome measures (PROMs), reoperations, and complications.
Methods
Databases queried included PubMed, OVID Medline, Embase, SCOPUS, Cochrane Central Register of Clinical Trials, and clinicaltrials.gov from their dates of inception to 3/21/2024. Studies were incorporated into this analysis if they had included patients with acute Lisfranc injuries and compared outcomes between PA and ORIF. PROMs, reoperations, and complications were captured. Results were reported as effect sizes (ES) and odds ratios (OR).
Results
There were eighteen studies included in this SRMA. Pooled data from 13/16 studies that reported AOFAS and VAS demonstrated better outcomes after PA compared to ORIF. AOFAS was 84.4 ± 28.5 after PA and 75.7 ± 29.0 after ORIF. VAS pain was 1.4 ± 2.7 after PA and 2.0 ± 3.3 after ORIF. There were 3 more studies that reported other PROMs and favored ORIF. Return to preinjury activity was 79.2% after PA and 65.7% after ORIF. The prevalence of midfoot post-traumatic arthritis was reported as 2.8% after PA and 17.3% after ORIF. Adjacent joint arthritis was not reported in the current literature. After PA, 77/438 (17.6%) patients underwent reoperations, and after ORIF, 514/802 (64.1%) patients underwent reoperations. After excluding planned hardware removals, relative rates of unplanned reoperations were 14.7% (n = 62/423) after PA and 38.3% (n = 181/472) after ORIF (p < 0.001). Non-operative complications occurred in 43/406 (10.6%) patients after PA and 95/753 (12.6%) patients after ORIF (p = 0.31). Meta-analyses demonstrated that AOFAS (ES: 0.41, CI 0.13, 0.68, p = 0.004) and VAS pain (ES: − 0.53, CI − 0.91, − 0.15, p = 0.006), and return to activity rates (OR: 2.71, CI 1.43, 6.39) favored PA over ORIF. Post-traumatic arthritis (OR: 0.29, CI 0.11, 0.77) and reoperations (OR: 0.16, CI 0.06, 0.44) were less prevalent after PA compared to ORIF.
Conclusion
This systematic review and meta-analysis suggested that PA provides better short- and medium-term outcomes in the setting of Lisfranc injuries when compared to ORIF with rigid fixation. Due to a lack of available clinical studies, the long-term effects of PA are largely unknown but may include increased adjacent joint arthritis, pain, and need for further surgery—especially in young and active patients. Future research demonstrating long-term outcomes would be helpful in clinical decision making.
期刊介绍:
"Archives of Orthopaedic and Trauma Surgery" is a rich source of instruction and information for physicians in clinical practice and research in the extensive field of orthopaedics and traumatology. The journal publishes papers that deal with diseases and injuries of the musculoskeletal system from all fields and aspects of medicine. The journal is particularly interested in papers that satisfy the information needs of orthopaedic clinicians and practitioners. The journal places special emphasis on clinical relevance.
"Archives of Orthopaedic and Trauma Surgery" is the official journal of the German Speaking Arthroscopy Association (AGA).